Vitamins

How Much Vitamin D Do You Need on Dulaglutide?

People on dulaglutide often overlook how GLP-1-driven appetite suppression quietly erodes vitamin D status by reducing dietary fat — the very carrier that shuttles D3 across the gut wall. Getting your 25(OH)D into the optimal range on a GLP-1 agonist requires a more precise approach than the standard 1,000 IU default most clinicians recommend.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
vitamin DdulaglutideGLP-1vitamin D3supplement dosingblood sugar
How Much Vitamin D Do You Need on Dulaglutide?

How Much Vitamin D Do You Need on Dulaglutide?

For most adults on dulaglutide, a maintenance dose of 2,000–4,000 IU of vitamin D3 daily is a reasonable starting point — but the real target is a serum 25(OH)D level of 40–60 ng/mL. The main caveat: dulaglutide's appetite suppression reduces overall food intake, which shrinks dietary vitamin D and fat intake needed for absorption. The exception is anyone with confirmed deficiency (25(OH)D below 20 ng/mL), who may need a short-term repletion protocol of 5,000–10,000 IU supervised by a clinician.

---

Why Dulaglutide Changes Your Vitamin D Equation

Dulaglutide (brand name Trulicity) is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction. It works by enhancing glucose-dependent insulin secretion, suppressing glucagon, and — critically — slowing gastric emptying. That slowing effect is powerful enough that the FDA updated labeling on oral medications to flag potential absorption interactions.

Vitamin D3 is a fat-soluble vitamin absorbed primarily in the small intestine through passive diffusion alongside dietary fats. When dulaglutide reduces overall caloric intake by 15–25% (a commonly observed effect in clinical trials), fat consumption often falls proportionally. Less dietary fat means less micellar solubilization of D3 — the process that shuttles the vitamin across the gut wall. A 2019 analysis of GLP-1 agonist users found that micronutrient deficiencies, including fat-soluble vitamins, were underreported and undertreated in this population (Mechanick et al., AACE Clinical Case Reports 2019).

Additionally, people starting dulaglutide are often already vitamin D insufficient. Type 2 diabetes is itself associated with lower 25(OH)D concentrations — a large cross-sectional study of 9,773 adults found an inverse relationship between fasting glucose, HbA1c, and serum vitamin D levels (Forouhi et al., Diabetologia 2008; PMID: 18286261). This means you may be arriving at dulaglutide therapy with a deficit that the drug's appetite effects can quietly worsen.

The gastric emptying slowdown also has a subtle but important implication for supplement timing. Because dulaglutide extends the time food spends in the stomach, peak bile acid secretion — which is required for fat emulsification and therefore D3 micellar formation — is delayed. This means even when you do eat fat, the window of optimal absorption may be shifted compared with someone not on a GLP-1. Taking your D3 supplement 30–60 minutes into a fat-containing meal rather than at the start may better align the supplement with peak luminal bile concentrations.

For a broader review of what lab markers tell you about vitamin D status, see Vitamin D3 Benefits and Side Effects: What Lab Markers Tell You.

---

What Does Vitamin D Actually Do — and Why Does It Matter on a GLP-1?

Vitamin D3 is converted in the liver to 25(OH)D (the storage form measured in blood tests) and then in the kidneys and peripheral tissues to 1,25(OH)₂D (calcitriol), the hormonally active form. Its receptors (VDRs) are expressed in virtually every tissue, including pancreatic beta cells, skeletal muscle, immune cells, and the gut.

For someone on dulaglutide, the most clinically significant roles are:

  • Beta-cell function: VDRs in pancreatic islets modulate insulin secretion. A meta-analysis of 28 randomized controlled trials found that vitamin D supplementation significantly improved HOMA-IR and fasting insulin in people with insulin resistance (Pittas et al., Journal of Clinical Endocrinology & Metabolism 2010; PMID: 20427173). Since dulaglutide also targets insulin secretion, maintaining adequate vitamin D status may support synergistic glycemic control.
  • Muscle and bone health: Dulaglutide-induced weight loss, while desirable, can accelerate bone turnover. A 2020 systematic review of GLP-1 receptor agonists found that rapid weight loss in this class was associated with measurable reductions in bone mineral density at the hip in some participants, particularly those with pre-existing insufficiency (Driessen et al., Obesity Reviews 2020; PMID: 32954597). Vitamin D insufficiency compounds this by impairing calcium absorption and raising fracture risk.
  • Immune regulation: Vitamin D modulates T-cell differentiation and cytokine production. Deficiency is associated with increased inflammatory markers — a concern in metabolic disease.
  • Gut barrier integrity: Emerging data suggests active vitamin D supports tight-junction proteins in the intestinal epithelium, relevant when gastric emptying is chronically altered.

---

How to Establish Your Actual Vitamin D Requirement

The question "how much vitamin D do I need on dulaglutide?" can't be answered without a baseline 25(OH)D level. The Endocrine Society and the NIH Office of Dietary Supplements define the following ranges:

25(OH)D LevelClassificationSuggested Action
< 12 ng/mLSevere deficiencyPhysician-supervised repletion, often 50,000 IU/week for 8–12 weeks
12–19 ng/mLDeficiency4,000–6,000 IU/day minimum; recheck in 3 months
20–29 ng/mLInsufficiency2,000–4,000 IU/day; optimize fat intake and sun exposure
30–39 ng/mLAdequate (lower)1,500–2,000 IU/day maintenance
40–60 ng/mLOptimal for most1,000–2,000 IU/day maintenance
> 100 ng/mLPotential toxicityReduce or discontinue supplementation

For people on dulaglutide specifically, targeting the 40–60 ng/mL range rather than the bare "sufficient" threshold of 30 ng/mL is a reasonable goal given the absorption challenges described above. Rechecking 25(OH)D at 3-month intervals when adjusting dose is standard practice.

One practical point: if you are taking an oral vitamin D3 supplement with a low-fat meal or on its own, absorption may be reduced by up to 32% compared with taking it alongside a fat-containing meal (Mulligan & Bhatt, Journal of Bone and Mineral Research 2010; PMID: 20200983). On dulaglutide, where fat intake may be low, consider a supplement formulated with an oil base or take it with whatever fat you do consume.

Body weight and adiposity also affect vitamin D pharmacokinetics in a clinically meaningful way. Vitamin D is sequestered in adipose tissue, which reduces its bioavailability in the circulation. As dulaglutide promotes weight loss, some of this sequestered D3 is gradually released — but during the weight-loss phase, net serum 25(OH)D can paradoxically remain low or decline if dietary and supplemental intake is not maintained. This is a nuance that practitioners often miss: even with active weight loss, you may need to maintain or temporarily increase your supplemental dose until body fat normalizes.

---

Vitamin D does not work in isolation. Two cofactors deserve attention for anyone on a GLP-1 agonist:

Vitamin K2 (MK-7): Directs calcium absorbed under vitamin D's influence into bone rather than soft tissue. At higher D3 doses (above 3,000 IU/day), co-supplementation with K2 is increasingly recommended. For a full breakdown of K2 safety considerations, Vitamin K2 Side Effects: Causes, Lab Markers, and Evidence-Based Supplement Support covers the clinical picture in detail.

Magnesium: Required for the enzymatic conversion of vitamin D3 into its active form. Magnesium deficiency can render vitamin D supplementation ineffective. A 2018 trial published in the American Journal of Clinical Nutrition found that magnesium status significantly modulated the effect of vitamin D on 25(OH)D levels — participants with low magnesium who received 400 mg/day of supplemental magnesium saw meaningfully larger increases in 25(OH)D than those taking vitamin D alone (Deng et al., Am J Clin Nutr 2018; PMID: 29294117). People with type 2 diabetes — the primary dulaglutide population — have higher rates of magnesium deficiency due to increased urinary losses.

Zinc: Modulates VDR expression and immune function alongside vitamin D. Reduced appetite from dulaglutide can lower dietary zinc intake, compounding this gap. Zinc is required for the synthesis of vitamin D-binding protein, which transports 25(OH)D in the bloodstream — another mechanism by which a secondary deficiency can undermine even well-dosed vitamin D supplementation.

Thinking about vitamin D in terms of a "stack" rather than a single nutrient is clinically more accurate, especially when dietary intake is compromised.

---

Comparing Vitamin D Approaches: What the Evidence Supports

FormBioavailabilityNotes for GLP-1 Users
D3 (cholecalciferol) in oil capsuleHighBest standard choice; fat carrier aids absorption
D3 in dry powder tabletModerateAbsorption may drop further with low-fat meals
D2 (ergocalciferol)LowerLess efficient at raising 25(OH)D; not preferred
D3 + K2 (MK-7) combinedHighPractical combination for cardiovascular and bone protection
High-dose prescription D2 (50,000 IU)VariableFor repletion under medical supervision only

Note that dulaglutide is a weekly subcutaneous injection — it does not interfere with vitamin D absorption through direct pharmacokinetic interaction. The issue is entirely secondary: reduced food intake and fat consumption alter the conditions for optimal absorption of a fat-soluble supplement.

For comparison, if you are on a different GLP-1 medication, the same principles apply with minor differences — How Much Vitamin D Do You Need on Liraglutide? covers the liraglutide-specific context in detail. Similarly, if you are managing PCOS alongside a GLP-1 prescription, vitamin D requirements can shift further — How Much Vitamin D Do You Need with PCOS? addresses that intersection specifically.

It is also worth noting that the D3-versus-D2 gap in raising serum 25(OH)D is not trivial in this population. A head-to-head trial found that D3 was approximately 87% more potent than D2 at raising and sustaining 25(OH)D concentrations over a 3-month period (Heaney et al., Journal of Clinical Endocrinology & Metabolism 2011; PMID: 21177785). For people whose absorption is already compromised by reduced fat intake on dulaglutide, choosing D3 over D2 is not simply a preference — it is a clinically meaningful decision.

---

What This Means for Your Formula

Personalizing vitamin D on dulaglutide is precisely the kind of problem that benefits from integrating lab data with supplement formulation. The standard approach — recommending 1,000 IU to everyone — leaves most dulaglutide users under-supplemented.

Ones addresses this by analyzing your uploaded 25(OH)D lab result alongside dietary patterns and health goals to determine which dose is actually indicated. Rather than guessing at 2,000 IU and hoping for the best, the platform calibrates the dose to what your bloodwork shows.

Specifically, Ones formulas can include:

  • Vitamin D3 + K2 (MK-7) dosed to your gap: D3 is paired with MK-7 in a single capsule because the science on soft-tissue calcium management supports using both together at higher D3 doses. This is particularly relevant for GLP-1 users experiencing weight loss who also need bone protection.
  • Magnesium Glycinate (from the Magnesium Complex blend): because vitamin D conversion is magnesium-dependent, addressing both gaps simultaneously produces better 25(OH)D outcomes than vitamin D alone — matching the mechanism shown in the Deng 2018 trial above.
  • Zinc: if dietary intake data or labs suggest deficiency, zinc supports VDR expression and vitamin D-binding protein synthesis, rounding out the immune and metabolic picture.

The formula comes in a 6- or 9-capsule daily plan determined by the AI based on what your findings actually show — not a plan you pick off a menu.

---

Key Takeaways

  • Dulaglutide indirectly lowers vitamin D status by reducing overall food and fat intake, impairing the absorption of this fat-soluble nutrient — not through direct pharmacological interference.
  • Target serum 25(OH)D of 40–60 ng/mL, not just the minimum sufficiency threshold of 30 ng/mL, to account for the absorption challenges on a GLP-1 agonist.
  • Most adults on dulaglutide need 2,000–4,000 IU/day at maintenance; confirmed deficiency requires a supervised repletion protocol.
  • Take D3 in an oil-based capsule with a fat-containing food — absorption can drop by up to 32% without dietary fat, and D3 is roughly 87% more potent than D2 at raising serum levels.
  • Cofactors matter: magnesium and K2 are essential partners for vitamin D to work properly; deficiency in either can blunt supplementation results, and zinc further supports VDR expression and transport protein synthesis.
  • Recheck 25(OH)D every 3 months when adjusting dose, especially in the first year on dulaglutide when dietary patterns are shifting most significantly, and remember that active weight loss can transiently suppress circulating 25(OH)D as adipose stores are mobilized.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting, stopping, or adjusting any supplement regimen, particularly when managing a chronic condition or taking prescription medications.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading